COVID-19 cases and restrictions weigh on economic data
- November 23, 2020
Client Relationship Management
Corporates | Kennett Square, PA
The market’s focus last week continued to laser in on all things coronavirus related. While investors applauded positive vaccine news out of Moderna and Pfizer early in the week, the continued surge in cases and increasing levels of restrictions weighed down on economic data as the week progressed.
It was a grim week as U.S. fatalities topped 250,000, with many states counting record-high infection rates. Weekly unemployment claims continued to trend higher as well, although other data released showed a better than expected rate of housing starts in October, suggesting the housing market continues to be buttressed by historically low mortgage rates.
Falling treasury yields
Ten-year treasury yields also fell after less than stellar retail sales data. They continued to hover around 10 basis points lower than the highs of a week earlier when Pfizer initially announced positive vaccine trial news. Similar struggles with COVID-19 related impacts overseas also appeared to jeopardize the prospects of a near-term recovery, and the IMF said in a statement on Thursday, “There are signs that the recovery may be losing momentum.” However, on a longer time horizon, the positive information coming from vaccine manufacturers seems to have investors looking ahead with a little more hope for a brighter future; approximately $4 billion USD has left U.S government bonds recently and about 10x that amount has made its way into global equity funds.
(Related insight: Read “How to use blend and extend interest rate swaps to optimize your hedging program”)
Abroad, post-Brexit negotiations planned for Thursday were partially put on hold when the EU President tested positive for COVID-19. Both sides seek an agreement to govern their trading relationship once the post-Brexit transition ends. Areas of contention continue to be fishing rights, competition rules and enforcement.
On the FX front, the U.S. dollar (USD) seemed caught between two opposing forces as tighter economic restrictions and potential further monetary easing competed with vaccine optimism. However, when looking more broadly at the global pandemic’s impact on the dollar, the USD has weakened meaningfully against several currencies since March 31st.
With the ongoing uncertainty in dollar strength, many USD functional corporates continue to fine tune their FX hedging programs to ensure the maximum levels of flexibility can be employed while still mitigating the desired levels of economic risk.
(Related insight: Read “How to increase FX hedging capacity while maintaining hedge accounting”)
The week ahead
This week many U.S. market participants and corporates will look forward to a shortened week, while consumer spending and new home sales stats are set to be released on Wednesday, prior to the start of the holiday.
Wishing all our readers a very happy Thanksgiving!
Chatham Hedging Advisors, LLC (CHA) is a subsidiary of Chatham Financial Corp. and provides hedge advisory, accounting and execution services related to swap transactions in the United States. CHA is registered with the Commodity Futures Trading Commission (CFTC) as a commodity trading advisor and is a member of the National Futures Association (NFA); however, neither the CFTC nor the NFA have passed upon the merits of participating in any advisory services offered by CHA. For further information, please visit chathamfinancial.com/legal-notices.
Transactions in over-the-counter derivatives (or “swaps”) have significant risks, including, but not limited to, substantial risk of loss. You should consult your own business, legal, tax and accounting advisers with respect to proposed swap transaction and you should refrain from entering into any swap transaction unless you have fully understood the terms and risks of the transaction, including the extent of your potential risk of loss. This material has been prepared by a sales or trading employee or agent of Chatham Hedging Advisors and could be deemed a solicitation for entering into a derivatives transaction. This material is not a research report prepared by Chatham Hedging Advisors. If you are not an experienced user of the derivatives markets, capable of making independent trading decisions, then you should not rely solely on this communication in making trading decisions. All rights reserved.20-0452
Our featured insights
Markets react to impeachment vote, stimulus plan, and pandemic outlook
The second full week of 2021 followed in the tracks of the prior week as even more historic geopolitical events unfolded and cases of the COVID-19 pandemic remained at record or near-record highs.
Treasuries, crypto, and oil bring us into 2021
The Georgia Senate election results were finalized during a tumultuous week, along with the official certification of Joe Biden as the next U.S. President.
Stock market gains mask weak economic end to 2020
While nations worldwide continue to distribute the COVID-19 vaccine, Americans have seen some progress in receiving their stimulus checks. The Treasury Department began depositing $600 checks in to Americans’ bank accounts last week, causing equity markets to rise.
Are all things merry and bright?
With less than 10 days to go before year-end, lawmakers reached a final agreement on a new coronavirus relief package expected to be around $900 billion. Market expectations are high that Congress can pass it into law this week, providing needed relief for businesses, communities, and households.
Vaccinations, stimulus talks, and Brexit lead the headlines in the final weeks of 2020
Positive vaccine news has the equities market poised for another rally as futures are pointing up heading into this week. The 10-year Treasury and 5-year swap rate are floating around 0.90% and 0.42%, respectively as the markets open this Monday.
LIBOR transition readiness checklist for corporates
This proprietary checklist is informed by Chatham Financial's team of hedging, regulatory, and accounting advisors with visibility across 100+ banks and 3,000+ clients. By taking these 12 key actions, your treasury and accounting teams can confidently prepare for the transition from LIBOR to SOFR.
Vaccine optimism fuels risk asset growth while rates remain rangebound
As of noon on November 30, global stock markets exhibited record growth during the month of November, fueled by successive vaccine announcements being queued up for emergency approval by the U.S. Government.
Vaccine news makes headlines, and the Fed issues its Financial Stability Report
The S&P 500 reached a historic high after news of a potential COVID-19 vaccine. However, those gains were erased as new infections surged. Fed Chairman Jerome Powell said that despite a potential vaccine, the U.S. economy will likely need additional support from Congress.